NCT05177289Recruiting
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia
Evaluating the Feasibility and Efficacy of Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-induced Alopecia: a Randomized Controlled Trial
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Jessa Hospital
- Participants (registry)
- 72
- Start
- February 2022
- Primary completion
- January 2025
- Study completion
- January 2030 (planned)
- Last registry update
- September 2023
- Countries
- Belgium
Conditions studied: Chemotherapy-induced Alopecia
Interventions: Theradome® LH80 pro, Scalp cooling
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.